BackFidelity Select Biotechnology Portfolio Overview

Fidelity Select Biotechnology Portfolio Current Cash

Track Fidelity Select Biotechnology Portfolio's current cash ($45M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$44.62M

Peer trimmed avg / median

Loading

Fidelity Select Biotechnology Portfolio Current Cash History

Loading

Fidelity Select Biotechnology Portfolio vs. peers: Current Cash Comparison

Loading

Fidelity Select Biotechnology Portfolio Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fidelity Select Biotechnology Portfolio (FBIOX) FAQ

Fidelity Select Biotechnology Portfolio (FBIOX) currently reports a current cash of $45M as of October 2023. Use the charts on this page to explore Fidelity Select Biotechnology Portfolio's current cash history and peer comparisons.

Fidelity Select Biotechnology Portfolio reported $45M in current cash as of October 2023. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $45M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fidelity Select Biotechnology Portfolio, and consider following FBIOX for alerts when major investors trade the stock.